(Updated - December 16, 2021 6:56 AM EST)

Cowen analyst Charles Rhyee initiates coverage on Pear Therapeutics (NASDAQ: PEAR) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE